Author

Savan Shah

Observed names: S. G. Shah, S. Shah

Institution: Moffitt Cancer Center

Observed institutions: University of South Florida, L V Prasad Eye Institute, Moffitt Cancer Center, University of Florida, Geron (United States)

ORCID: 0000-0001-8589-0548

Observed ORCID: 0000-0001-8589-0548

OpenAlex ID: A5086828809

Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation

2017 · Andrew T. Kuykendall, Savan Shah, et al. · Annals of Hematology · 134

Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?

1997 · N.B. Kumar, K. Allen, et al. · Breast Cancer Research and Treatment · 49

15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis

2024 · Mahati Paravathaneni, Houssein Safa, et al. · EClinicalMedicine · 23

Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy

2021 · Anthony M. Hunter, Najla Al Ali, et al. · Leukemia Research · 23

One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK)

2010 · M. Fernandes, P. Reddy, et al. · British Journal of Ophthalmology · 2

Veterans Affairs hematology/oncology clinic video telehealth experience.

2021 · Nikesh Shah, Savan Shah, et al. · Journal of Clinical Oncology · 1

667P Cost effectiveness of immune checkpoint inhibitors in combination with targeted therapies in metastatic renal cell carcinoma

2021 · N. Mason, Y. Kim, et al. · Annals of Oncology · 1

Investigating Patient Characteristics and Outcomes of Myelofibrosis Patients with Hyperleukocytosis

2018 · Savan Shah, Chetasi Talati, et al. · Blood · 1

CO77 Impact of Imetelstat Treatment on PROs and Health Care Resource Utilization in Heavily Transfused Non-Del(5Q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory to Erythropoiesis Stimulating Agents: IMerge Phase 3 Trial

2023 · M. Sekeres, V. Santini, et al. · Value in Health

Somatic mutations predict immune-related adverse events (irAEs) and survival following CTLA4 blockade in melanoma patients.

2021 · Savan Shah, Xiaoqing Yu, et al. · Journal of Clinical Oncology

Overview of Insightful Systemic Approaches

2021 · Savan Shah, Malek Saad, et al. · Springer eBooks

A Fatal Case of Acute Cholangitis Caused by Aeromonas Sobria

2019 · S. Shah, H.H. Hatoum, et al. · American Journal of Respiratory and Critical Care Medicine

Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis

2017 · Savan Shah, Chetasi Talati, et al. · Blood

A Rare Overlapping Presentation of Crohnʼs Disease and Granulomatosis With Polyangiitis

2017 · Savan Shah, Rupal Patel, et al. · The American Journal of Gastroenterology

Works count: 14

Citation count: 234

H-index: 4

I10-index: 4